3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
7
Recruiting
2
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Peritoneal Metastases From Gastric Cancer
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Epstein-Barr Virus Infections
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
4
Cisplatin
4
nedaplatin
2
Heavy Ion Radiotherapy
2
Gemcitabine
2
donafenib
1
apatinib
1
Varenicline
1
Valganciclovir
1
Therapeutics
1
Tegafur
1
S 1 (combination)
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Nivolumab
1
Nicotine Replacement Therapy
1
Mitomycin
1
Ifosfamide
1
Fluorouracil
1
Eucalyptus Oil
1
Epirubicin
1
Doxorubicin
1
Coal Tar
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Carboplatin
1
Bupropion
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Nasopharyngeal Carcinoma
×
apatinib
×
Clear all
NCT02874651
2022-01-11
ADVANCE
Sun Yat-sen University
Phase 2
Terminated
25 enrolled